Development Level

Tbio 17 | 11,445
Tdark 8 | 6,588
Tchem 2 | 1,598

Disease

Breast cancer 12 | 3,578
ovarian cancer 11 | 8,520
psoriasis 11 | 6,694
Carcinoma 10 | 11,493
lung cancer 10 | 4,740
invasive ductal carcinoma 9 | 2,951
lung adenocarcinoma 9 | 2,716
ductal carcinoma in situ 8 | 1,745
breast carcinoma 7 | 1,638
Cancer 6 | 2,499
non-small cell lung cancer 6 | 2,890
Multiple myeloma 5 | 1,332
atypical teratoid / rhabdoid tumor 5 | 5,112
cystic fibrosis 5 | 1,696
intraductal papillary-mucinous neoplasm (IPMN) 5 | 3,291
pancreatic cancer 5 | 2,398
Schizophrenia 4 | 1,160
cutaneous lupus erythematosus 4 | 1,057
glioblastoma 4 | 5,792
group 3 medulloblastoma 4 | 4,104
intraductal papillary-mucinous carcinoma (IPMC) 4 | 2,989
malignant mesothelioma 4 | 3,232
non-small cell lung carcinoma 4 | 317
osteosarcoma 4 | 7,950
Breast Neoplasms 3 | 445
Cleft Palate 3 | 271
Connective tissue disease 3 | 62
Lupus erythematosus 3 | 57
Mammary Neoplasms 3 | 425
colon cancer 3 | 1,478
group 4 medulloblastoma 3 | 1,855
medulloblastoma, large-cell 3 | 6,241
pituitary cancer 3 | 1,972
spina bifida 3 | 1,074
Astrocytoma, Pilocytic 2 | 3,081
Disease Models, Animal 2 | 155
Endometriosis 2 | 540
Prostatic Neoplasms 2 | 495
Retinitis pigmentosa 11 2 | 59
Retinitis pigmentosa 20 2 | 5
Thyroiditis 2 | 29
Waldenstrons macroglobulinemia 2 | 765
diabetes mellitus 2 | 1,728
gastric cancer 2 | 459
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,955
lung carcinoma 2 | 2,843
nasopharyngeal carcinoma 2 | 1,058
pancreatic carcinoma 2 | 562
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
posterior fossa group A ependymoma 2 | 468
subependymal giant cell astrocytoma 2 | 2,287
Adenocarcinoma of lung 1 | 142
Alzheimer's disease 1 | 658
Ankylosing spondylitis 1 | 140
Arthritis 1 | 290
Atopic dermatitis 1 | 952
Brain Ischemia 1 | 110
Cardiomyopathies 1 | 110
Cocaine-Related Disorders 1 | 92
Depressive disorder 1 | 409
Down syndrome 1 | 499
Esophageal Squamous Cell Carcinoma 1 | 77
Eye disease 1 | 62
Fanconi anemia 1 | 56
Female infertility 1 | 30
Gastric antral vascular ectasia 1 | 10
Gliosis 1 | 56
Heart disease 1 | 306
Hyperalgesia 1 | 83
Infertility, Female 1 | 28
Influenza 1 | 142
Kidney Neoplasm 1 | 29
Kidney Neoplasms 1 | 37
Kidney disease 1 | 430
Lung Neoplasms 1 | 232
Lung disease 1 | 142
Malaria 1 | 160
Male infertility 1 | 206
Mental Depression 1 | 333
Neoplasm Invasiveness 1 | 161
Neoplasm Metastasis 1 | 168
Neoplasm Recurrence, Local 1 | 37
Nerve Degeneration 1 | 121
Neurodegenerative disease 1 | 414
Nijmegen breakage syndrome 1 | 24
Ovarian Neoplasms 1 | 102
Parkinson's disease 1 | 392
Primary ciliary dyskinesia 1 | 76
Squamous cell carcinoma 1 | 129
Squamous cell carcinoma of esophagus 1 | 77
Stomach Neoplasms 1 | 300
Testicular cancer 1 | 25
Toxic encephalopathy 1 | 141
Vaccinia 1 | 36
active ulcerative colitis 1 | 764
adrenocortical carcinoma 1 | 1,428
hepatocellular carcinoma 1 | 547
inflammatory breast cancer 1 | 286
ovarian neoplasm 1 | 99
pediatric high grade glioma 1 | 1,064

Tissue

Endocrine System 27 | 18,159
Blood and immune system 26 | 16,909
Cardiovascular System 26 | 15,192
Digestive Tract 26 | 17,369
Female tissues 26 | 17,400
Liver and Pancreas 26 | 16,750
Male tissues 26 | 17,142
Nervous System 26 | 16,725
Respiratory system 26 | 16,393
Skin and soft tissues 26 | 17,230
Urinary Tract 26 | 16,678

Target Family

Non-IDG 24 | 12,091
Transcription Factor 2 | 1,400
Kinase 1 | 634

Reactome Pathway

RNA Polymerase I Promoter Open... 27 | 27
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Histone H2A.J H2AFJ Tdark Non-IDG -0.00172 0.83 99
Histone H2B type 1-N HIST1H2BN Tbio Non-IDG -1.51422 30.2 60
Histone H2B type 1-L HIST1H2BL Tdark Non-IDG 0.35 0.40 48
Histone H2B type 1-M HIST1H2BM Tdark Non-IDG 0.17 0.33 21
Histone H2A type 1-J HIST1H2AJ Tdark Non-IDG -0.13212 1.19 16
Histone H2A type 1-B/E HIST1H2AB Tbio Non-IDG -1.27041 18.5 133
Histone H2A type 2-A HIST2H2AA3 Tbio Non-IDG -3.04065 999.3 88
Methyl-CpG-binding domain protein 2 MBD2 Tchem Transcription Factor -1.74971 47.7 297
Histone H2B type 1-H HIST1H2BH Tbio Non-IDG 0.16 0.59 55
Histone H2A type 1-C HIST1H2AC Tdark Non-IDG -0.15970 0.82 25